IPO Year: 2026
Exchange: NASDAQ
SCHEDULE 13D - Alamar Biosciences, Inc. (0002104204) (Subject)
SCHEDULE 13D - Alamar Biosciences, Inc. (0002104204) (Subject)
EFFECT - Alamar Biosciences, Inc. (0002104204) (Filer)
S-8 - Alamar Biosciences, Inc. (0002104204) (Filer)
8-K - Alamar Biosciences, Inc. (0002104204) (Filer)
POS AM - Alamar Biosciences, Inc. (0002104204) (Filer)
Fastest customizable press release news feed in the world
SHANGHAI, April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time. Alamar (NASDAQ:ALMR) issued shares at a price of $17 per share and opened at $22.6 per share with a market capitalization of approximately $1.5 billion. Qiming Venture Partners led Alamar's Series A financing in 2020 and continued to fund the company's development in the following Series B and Series C rounds. Before the company's IPO, Qiming Venture Partners held approximately 19.2% stake in Alamar and was one of its most important institutional investors.Fo
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
4 - Alamar Biosciences, Inc. (0002104204) (Issuer)